TABLE 3.
| TABLE 3a Regression Coefficients for the Relationship between Survivorship Status (Active vs. Disease-free) and Health Status (n=761) | ||||||
|---|---|---|---|---|---|---|
| SF-36 Physical Component Summary (PCS) |
SF-36 Mental Component Summary (MCS) |
|||||
| Model Covariates | R2 | STS vs. Active b (Std error) | LTS vs. Active b (Std error) | R2 | STS vs. Active b (Std error) | LTS vs. Active b (Std error) |
| I. SS | .028 | 6.2 (2.0)*** | 4.6 (1.4)*** | .018 | 4.9 (2.0)*** | 4.0 (1.5)** |
| II. SS+DEM | .222 | 4.8 (1.3)*** | 4.2 (1.1)*** | .076 | 4.8 (1.4)*** | 3.7 (1.2)** |
| III. SS+DEM+CLN | .256 | 2.6 (1.9) | 0.9 (1.8) | .103 | 7.1 (2.1)*** | 5.2 (2.0)** |
| IV. SS+DEM+CLN+HTH | .447 | 1.0 (1.6) | 0.5 (1.5) | .184 | 6.1 (2.0)** | 5.0 (1.9)** |
| V. SS+DEM+CLN+HTH+PSO | .459 | 0.7 (1.6) | 0.5 (1.5) | .290 | 5.5 (1.9)** | 5.1 (1.8)** |
| VI. SS+DEM+CLN+HTH+PSO+PTS | .480 | −0.2 (1.6) | −0.7 (1.5) | .519 | 2.0 (1.6) | 1.2 (1.5) |
| TABLE 3b Regression Coefficients for the Relationship between Survivorship Status (Active vs. Disease free) and QOL (n=761) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| FACT-G |
IOC Positive Impact |
IOC Negative Impact |
|||||||
| Model Covariates | R2 | STS vs. Active b (Std error) | LTS vs. Active b (Std error) | R2 | STS vs. Active b (Std error) | LTS vs. Active b (Std error) | R2 | STS vs. Active b (Std error) | LTS vs. Active b (Std error) |
| I. SS | .071 | 13.3 (4.2)*** | 12.4 (3.0)*** | .021 | 1.6 (0.2)*** | 1.2 (0.1)*** | .025 | −1.0 (0.1)** | −1.3 (0.1)*** |
| II. SS+DEM | .160 | 12.6 (2.0)*** | 11.7 (1.7)*** | .136 | 1.6 (0.4)*** | 1.3 (0.3)*** | .113 | −1.1 (0.3)** | −1.2 (0.3)*** |
| III. SS+DEM+CLN | .200 | 13.1 (2.9)*** | 10.1 (2.7)*** | .188 | 1.6 (0.6)** | 1.4 (0.5)* | .210 | −1.2 (0.5)* | −1.0 (0.4)* |
| IV. SS+DEM+CLN+HTH | .321 | 10.6 (2.7)*** | 9.2 (2.5)*** | .195 | 1.6 (0.6)** | 1.3 (0.5)* | .272 | −0.9 (0.5)* | −0.9 (0.4)* |
| V. SS+DEM+CLN+HTH+PSO | .489 | 7.9 (2.4)*** | 8.1 (2.2)*** | .315 | 1.5 (0.5)** | 1.1 (0.5)* | .422 | −0.7 (0.4) | −0.9 (0.4)* |
| VI. SS+DEM+CLN+HTH+PSO+ PTS | .677 | 3.7 (1.9)* | 2.8 (1.8) | .317 | 1.5 (0.5)** | 1.1 (0.5)* | .597 | −0.0 (0.3) | −0.1 (0.3) |
SF-36: Medical Outcomes Study-Short form; FACT-G: Functional Assessment of Cancer Therapy-General; IOC: Impact of Cancer; R2: proportion of variation in the dependent variable explained by the regression equation; STS: short-term disease-free survivor (<5 years) ; LTS: long-term disease-free survivor (≥5 years); b: unstandardized regression coefficient (slope); SS: survivorship status; DEM: demographics (gender, race, ethnicity, age, income, education, marital status, employment status); CLN: clinical (histology, stage, surgery, radiation therapy, chemotherapy, bone marrow/stem cell transplant, biologic therapy, recurrence, number of oncology-related visits, site of treatment); HTH: general health (other cancer excluding skin, co-morbidity, years since last physical exam); PSO: Psychosocial (social support, appraisal of life threat and treatment intensity, employment and insurance issues); PTS: (post-traumatic stress).
P<.05
P<.01
P<.001.